Clinical Trials Logo

Adenocarcinoma of Prostate clinical trials

View clinical trials related to Adenocarcinoma of Prostate.

Filter by:

NCT ID: NCT04687969 Recruiting - Prostate Cancer Clinical Trials

Multimodal Machine Learning Characterization of Solid Tumors

Start date: October 23, 2022
Phase:
Study type: Observational

This research study wants to develop advanced imaging methods to more accurately characterize prostate cancer or solid tumor aggressiveness. This observational study involves [18F]DCFPyL positron emission tomography and magnetic resonance imaging (PET/MRI)

NCT ID: NCT03518853 Completed - Clinical trials for Adenocarcinoma of Prostate

Short Course Radiotherapy for Localized Prostate Cancer

SHORT
Start date: December 2013
Phase: N/A
Study type: Interventional

Hypofractionated external beam radiotherapy has been clinically used for localized prostate cancer in view of the low estimated alpha/beta ratio of prostate cancer cells. Moderate fraction sizes of <4Gy per fraction has been investigated in several phase II/III studies and has been found to be well tolerated with comparable biochemical control in comparison with standard fractionated dose-escalated regimens. Fraction sizes of > 4 Gy has also been investigated in single center studies. However, its toxicity and disease control outcomes is less well known. In this Phase I/II single arm study the investigators aim to treat non-metastatic prostate cancer with stageT1-T4N0M0 and Prostate Specific Antigen (PSA) <60 ng/ml to a regimen of 35Gy in 5 fractions delivered once a week with a view to determine acute toxicity, biochemical control with PSA and late toxicity.

NCT ID: NCT02672449 Recruiting - Clinical trials for Adenocarcinoma of Prostate

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Start date: May 2015
Phase: N/A
Study type: Interventional

The aim of this research project is to test the feasibility and safety of a new treatment schedule for high risk prostate cancer that allows the administration of high doses to the prostate tumor with a mixed beam approach of carbon ions boost followed by pelvic IMRT.

NCT ID: NCT02342626 Completed - Clinical trials for Adenocarcinoma of Prostate

Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer

Start date: January 2015
Phase: N/A
Study type: Interventional

The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.

NCT ID: NCT02258087 Recruiting - Clinical trials for Adenocarcinoma of Prostate

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

PROMOBRA
Start date: September 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Investigators compare in a randomized clinical trial the results and side effects of high-dose- and low-dose-rate brachytherapy as monotherapy in the treatment of early, organ confined prostate cancer patients.

NCT ID: NCT02025361 Completed - Clinical trials for Adenocarcinoma of Prostate

Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy

Start date: February 2009
Phase: Phase 4
Study type: Interventional

Transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the gold standard method for prostat cancer diagnosis. Cancer detection rate is an important issue in TRUS-Bx. Effective biopsy protocol is necessary to enhance cancer detection rate during the procedure. Patient tolerance may improve the protocol effectiveness and quality. Adequate patient tolerance with optimal local anesthesia may enhance cancer detection rate in TRUS-Bx.

NCT ID: NCT02024685 Terminated - Clinical trials for Adenocarcinoma of Prostate

Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

Start date: August 2013
Phase: N/A
Study type: Interventional

This is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures. We will use a randomized trial to test the hypothesis that a decision analysis model that provides individualized estimates of quality-adjusted disease-free survival for each of the treatment options for clinically localized prostate cancer will lead to higher quality treatment decisions congruent with a patient's values leading to improved decisional regret and treatment satisfaction. In this trial, all patients would be evaluated at baseline for their utilities for various clinically important health states. The control arm will receive counseling regarding treatment options using standard patient-physician interactions and nomogram-predicted probabilities of treatment outcome for the various treatment options and they will be unaware of the decision analysis recommendation. The treatment arm would be counseled using standard patient-physician interactions and they would also be provided with a personalized treatment recommendations based on the decision analysis model prior to treatment selection. The primary endpoint of this study will be regret-free survival at 2 years after treatment. There will be a 1:1 randomization. A random permuted design will be used to assure approximate balanced number of patients in the two groups over time.

NCT ID: NCT01994239 Active, not recruiting - Clinical trials for Adenocarcinoma of Prostate

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

GETUG-AFU22
Start date: December 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to select the best therapeutic strategy in studying the effectiveness of the association of a short duration hormonal therapy and radiotherapy compared with radiotherapy alone, in patients with a detectable PSA after radical prostatectomy.

NCT ID: NCT01952223 Active, not recruiting - Clinical trials for Adenocarcinoma of Prostate

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

PEACE2
Start date: December 2013
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess the effect of neoadjuvant cabazitaxel and pelvic radiotherapy in combination with androgen deprivation therapy (ADT)-radiotherapy on clinical progression-free survival in patients with high-risk localized prostate cancer (with a stringent selection of patients with at least 2 high-risk features), in a 2 by 2 factorial trial.

NCT ID: NCT01913717 Active, not recruiting - Clinical trials for Adenocarcinoma of Prostate

Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion

Start date: January 2014
Phase: N/A
Study type: Interventional

The present research project aims to improve the current treatment for prostate-confined tumor, evaluating the safety and feasibility of a very short hypofractionated radiotherapy schedule administered with one of the best available dose delivery systems. The study will include 2 sub-studies (in-silica and clinical study) and 4 tasks.